Key Financial Data Of Group

TOWA PHARMACEUTICAL CO.,LTD. - Filing #7252380

Concept As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
Key financial data of group
Business results of group
Net sales
259,594,000,000 JPY
172,269,000,000 JPY
149,221,000,000 JPY
227,934,000,000 JPY
124,003,000,000 JPY
208,859,000,000 JPY
123,302,000,000 JPY
165,615,000,000 JPY
115,346,000,000 JPY
154,900,000,000 JPY
Ordinary profit (loss)
26,152,000,000 JPY
27,532,000,000 JPY
27,231,000,000 JPY
24,477,000,000 JPY
8,542,000,000 JPY
5,141,000,000 JPY
22,493,000,000 JPY
22,739,000,000 JPY
18,630,000,000 JPY
18,677,000,000 JPY
Profit (loss) attributable to owners of parent
18,986,000,000 JPY
16,173,000,000 JPY
2,201,000,000 JPY
15,914,000,000 JPY
13,958,000,000 JPY
Comprehensive income
18,645,000,000 JPY
21,949,000,000 JPY
7,825,000,000 JPY
17,960,000,000 JPY
14,469,000,000 JPY
Net assets
171,625,000,000 JPY
168,739,000,000 JPY
155,893,000,000 JPY
150,530,000,000 JPY
133,798,000,000 JPY
136,894,000,000 JPY
132,169,000,000 JPY
130,575,000,000 JPY
116,599,000,000 JPY
116,658,000,000 JPY
Total assets
470,823,000,000 JPY
427,016,000,000 JPY
430,653,000,000 JPY
383,843,000,000 JPY
333,620,000,000 JPY
371,347,000,000 JPY
332,097,000,000 JPY
299,893,000,000 JPY
245,668,000,000 JPY
230,501,000,000 JPY
Net assets per share
3,486.40
3,427.77
3,167.27
3,058.31
2,718.28
2,781.17
2,685.18
2,652.79
2,369.21
2,370.40
Basic earnings (loss) per share
385.71
428.66
398.21
328.59
128.60
44.72
331.57
323.36
277.39
283.62
Diluted earnings per share
324.22
316.19
265.95
271.93
Equity-to-asset ratio
0.365 xbrli:pure
0.395 xbrli:pure
0.362 xbrli:pure
0.392 xbrli:pure
0.401 xbrli:pure
0.369 xbrli:pure
0.398 xbrli:pure
0.435 xbrli:pure
0.475 xbrli:pure
0.506 xbrli:pure
Rate of return on equity
0.116 xbrli:pure
0.132 xbrli:pure
0.138 xbrli:pure
0.110 xbrli:pure
0.048 xbrli:pure
0.016 xbrli:pure
0.132 xbrli:pure
0.128 xbrli:pure
0.123 xbrli:pure
0.126 xbrli:pure
Price-earnings ratio
6.95 xbrli:pure
6.25 xbrli:pure
7.29 xbrli:pure
8.84 xbrli:pure
14.74 xbrli:pure
42.37 xbrli:pure
8.29 xbrli:pure
8.50 xbrli:pure
8.81 xbrli:pure
8.61 xbrli:pure
Net cash provided by (used in) operating activities
23,401,000,000 JPY
8,212,000,000 JPY
2,544,000,000 JPY
22,129,000,000 JPY
12,008,000,000 JPY
Net cash provided by (used in) investing activities
-31,287,000,000 JPY
-40,394,000,000 JPY
-30,284,000,000 JPY
-59,729,000,000 JPY
-9,100,000,000 JPY
Net cash provided by (used in) financing activities
21,567,000,000 JPY
35,407,000,000 JPY
17,481,000,000 JPY
46,540,000,000 JPY
184,000,000 JPY
Cash and cash equivalents
45,460,000,000 JPY
29,650,000,000 JPY
24,257,000,000 JPY
32,830,000,000 JPY
22,915,000,000 JPY
Number of employees
4,788 xbrli:pure
2,790 xbrli:pure
908 xbrli:pure
3,880 xbrli:pure
4,588 xbrli:pure
2,684 xbrli:pure
2,591 xbrli:pure
4,298 xbrli:pure
4,078 xbrli:pure
2,449 xbrli:pure
3,456 xbrli:pure
2,408 xbrli:pure
Average number of temporary employees
767 xbrli:pure
625 xbrli:pure
xbrli:pure
767 xbrli:pure
761 xbrli:pure
651 xbrli:pure
681 xbrli:pure
837 xbrli:pure
852 xbrli:pure
705 xbrli:pure
684 xbrli:pure
684 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.